Jana Medical adds eighth board nominee ahead of November 10 EGM
Jana Medical Company has expanded its list of qualified board candidates to eight ahead of its November 10 Extraordinary General Meeting (EGM). The change adds an applicant who met the submission deadline but was omitted from the board's initial recommendation.
Omar Al Nuaimi
Board approves revised candidate list
The company announced the change in a supplementary disclosure after the board approved adding the candidate. Jana Medical described the revision as an administrative update with no financial impact.
Shareholders have been invited to read the completed resumes for all eight nominees before voting at the EGM.
Nominees disclose holdings and experience
The candidate materials identify Eid Sultan Aayed Al Otaibi as the holder of 412,732 Jana Medical shares. The legal entity he represents owns another 360,269 shares.
Haroon Rashid Rabah Abu Shehada's profile cites his experience turning around a joint-stock agricultural company. According to the nominee, that company went from having lost more than 70% of its capital to recording profits of SAR 5 million.
Financial results and leadership changes
Jana Medical joined Nomu, Saudi Arabia's parallel market, on December 1, 2024. Argaam reported a debut price of SAR 44 per share, following an offering of 642,500 shares that was 150.4% covered.
For 2024, Jana Medical recorded losses of SAR 23.2 million, of which SAR 19.8 million came in the second half, according to Argaam. On April 7, 2025, the outlet reported that accumulated losses had reached 40.55% of the company's capital.
The company also underwent a change in executive leadership. Argaam reported CEO Ziyad Al-Sulais's resignation on January 11, 2026. He had been appointed on November 23, 2025, following the acting CEO's resignation.
